K
KnowMBAAdvisory
Industry briefยทSpecialty Pharmacy

AI and operations consulting for specialty pharmacy

AI, automation, and operations consulting for specialty pharmacy operators. Solve PBM dynamics, prior-auth, hub-services, and the operating model that separates the high-touch specialty therapy from the commodity dispense.

๐ŸŽฏ

Best fit

COOs, CIOs, heads of operations, and clinical-and-commercial leaders at specialty pharmacy operators, PBM-affiliated specialty pharmacies, hospital and health-system specialty programs, and biopharma hub-services partners.

What's hurting

Signs you need this in Specialty Pharmacy.

The operational tells we hear most often when teams in this industry reach out for a diagnostic.

PBM dynamics โ€” formulary placement, network access, contract terms, DIR fees, and rebate flow โ€” shape the realized economics on every script and the operating model has to be defended every contract cycle.

Prior authorization and benefits investigation are the gating workflow on every specialty start; the cycle time and approval rate are commercial and clinical KPIs.

Hub services for biopharma manufacturers (patient assistance, copay support, adherence, REMS) is a high-touch operating model that runs on data, calls, and document workflow.

Specialty-product cold-chain logistics, dispensing accreditation (URAC, ACHC), and limited-distribution-drug (LDD) network access are operating prerequisites with sustained compliance overhead.

Adherence, persistence, and patient-reported-outcome workflows are the clinical-and-commercial differentiator and the data is fragmented across pharmacy, provider, and manufacturer.

Integration with EHRs, hub partners, and specialty-pharmacy network partners is brittle and expensive; the IT footprint is a competitive lever.

Where AI delivers

AI opportunities for Specialty Pharmacy.

Specific, scoped use cases where AI and automation move the needle in this industry โ€” not generic LLM hype.

01

Prior-authorization automation โ€” document drafting, payer-policy parsing, and approval-cycle acceleration on the specialty-start workflow.

02

Benefits-investigation AI โ€” payer-and-PBM coverage, copay, and patient-financial-responsibility automation.

03

Adherence and persistence AI โ€” predictive intervention models for patient outreach and refill workflow.

04

Hub-services automation โ€” patient-assistance application processing, copay-card workflow, and REMS compliance support.

05

Cold-chain and dispense AI โ€” temperature-excursion monitoring, dispensing-error prevention, and accreditation-evidence automation.

06

Manufacturer-and-PBM data AI โ€” integrated data-and-reporting workflow that supports the contracted analytics and audit obligations.

Where we focus

Transformation themes

The structural shifts we keep seeing in this industry. Most engagements touch two or three of these at once.

PBM and contract operating discipline โ€” the formulary, network, DIR, and rebate workflow as a sustained capability.

Specialty-start workflow โ€” the prior-auth, benefits-investigation, and patient-onboarding operating model.

Hub-services and biopharma partnership โ€” the operating model that supports manufacturer programs (patient assistance, copay, adherence, REMS).

Accreditation and compliance โ€” the URAC, ACHC, LDD, and cold-chain framework as an operating prerequisite.

Adherence and outcomes โ€” the clinical-and-commercial discipline that differentiates the specialty-pharmacy operating model.

Integration architecture โ€” the EHR, hub, manufacturer, and PBM-partner integrations the platform needs.

What we ship

Services for Specialty Pharmacy.

The engagement shapes that fit this industry's reality. Each one ends with a working system, not a deck.

Proof

Real cases in Specialty Pharmacy.

What this looks like when it works โ€” operators who applied the same patterns and the lessons that survived contact with reality.

๐ŸŸฅ

CVS Specialty (CVS Health)

ongoing

CVS Specialty is one of the largest US specialty pharmacies, operating as part of CVS Health alongside the CVS Caremark PBM and the CVS retail-pharmacy and Aetna health-plan businesses. The integrated operating model โ€” specialty pharmacy plus PBM plus health plan plus retail โ€” is consistently cited as the defining vertically integrated specialty operating example, with sustained investment in clinical programs, adherence services, and the digital-front-door for specialty patients and providers.

One of the largest US specialty pharmacies (publicly disclosed)
Operating scope
Specialty pharmacy plus CVS Caremark PBM plus CVS retail plus Aetna health plan (publicly disclosed)
Integrated operating model
Sustained investment in clinical management, adherence, and digital-front-door for specialty patients and providers
Clinical programs

Lesson

Specialty-pharmacy economics at scale are unlocked by vertical integration with the PBM, the health plan, and the retail footprint. The integrated operators capture the formulary, the network, and the adherence operating model; the standalone specialty operators compete on clinical-program differentiation and limited-distribution access.

๐ŸŸฆ

Walgreens AllianceRx

ongoing

AllianceRx Walgreens Pharmacy is a national specialty and home-delivery pharmacy operator, originally a joint venture with Prime Therapeutics and consolidated under Walgreens Boots Alliance. The operating model spans specialty therapies, home-delivery maintenance medications, and integrated patient programs, and is consistently cited as a defining national specialty operator alongside CVS Specialty and the other large PBM-affiliated operators.

National specialty and home-delivery pharmacy operator (publicly disclosed)
Operating scope
Specialty therapies, home-delivery maintenance medications, and integrated patient programs (publicly disclosed)
Operating model
One of the defining national specialty pharmacy operators (publicly disclosed)
Industry positioning

Lesson

National specialty pharmacy economics are won by integrating specialty and home-delivery operating models with PBM and payer relationships. The operators that build the integrated home-delivery-and-specialty platform capture the maintenance refill economics that fund the specialty-program clinical investment; the ones that stay specialty-only carry the cost-load alone.

๐Ÿ’Š

Hypothetical: independent specialty pharmacy

2024-2025

An independent specialty pharmacy serving 14,000 patients across oncology, rheumatology, and rare-disease therapies was running prior-auth turnaround at 6.4 days, a benefits-investigation workflow that produced inconsistent patient-financial-responsibility quotes, and an adherence program that touched only 38% of high-risk patients in any given quarter. We deployed an AI prior-auth drafter trained on payer-specific templates, rebuilt benefits-investigation around a structured payer-policy database, and stood up a predictive-adherence model that prioritized outreach by predicted-discontinuation risk. Prior-auth dropped inside 48 hours, patient-financial-responsibility quotes normalized, and adherence touchpoints scaled to the full high-risk cohort.

6.4 days โ†’ 1.7 days
Prior-auth turnaround
Inconsistent โ†’ standardized with payer-policy database
Benefits-investigation accuracy
38% โ†’ 96%
High-risk-cohort adherence touch coverage

Lesson

Independent specialty pharmacy economics are won by collapsing prior-auth time, standardizing benefits-investigation, and prioritizing adherence outreach by predicted risk. The operators that try to scale clinical staff linearly hit the cost ceiling; the ones that wire the AI-and-workflow stack into the start-and-adherence operating model compound the patient and contract economics.

Start a project for
specialty pharmacy.

Share the industry-specific bottleneck and the desired outcome. KnowMBA will scope the right audit, sprint, or build from there.

Typical response time: 24h ยท No retainer required